🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will estimate how fast two antiepileptic drugs (Levetiracetam an...
Status
Completed
Location
Ep0074 001
Start Date
2015-11
Trial ID
NCT02602860
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) ...
Status
Completed
Location
Ep0083 905
Start Date
2017-08-22
Trial ID
NCT03083665
Treatments Being Tested
The main purpose of this study is to see whether brivaracetam has a faster ...
Status
Completed
Location
The Comprehensive Epilepsy Care Center For Children And Adults
Start Date
2018-06-01
Trial ID
NCT03580707
Treatments Being Tested
This is a multicenter, open-label, 4-arm, randomized, parallel-group study ...
Status
Completed
Location
001
Start Date
2011-08
Trial ID
NCT01405508
Treatments Being Tested
The primary objective of this study is to compare the efficacy of Brivarace...
Status
Terminated
Location
3
Start Date
2014-03
Trial ID
NCT02088957
This study will evaluate the efficacy and safety of Brivaracetam to support...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00464269
Treatments Being Tested
Trial N01395 is to evaluate the reduction of nonpsychotic behavioral side e...
Status
Completed
Location
103
Start Date
2012-07
Trial ID
NCT01653262
Treatments Being Tested
Antiepileptic Drugs (AEDs) are the main treatment for epilepsy; however, on...
Status
Terminated
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00699283
Treatments Being Tested
The purpose of the study is to evaluate the long-term safety and tolerabili...
Status
Recruiting
Location
Ep0156 259
Start Date
2021-03-11
Trial ID
NCT04715646
Treatments Being Tested
The purpose of the study is to test the efficacy, safety and tolerability o...
Status
Completed
Location
N01269 115
Start Date
2021-07-29
Trial ID
NCT04666610
Treatments Being Tested